BeyondSpring, Inc.

( )
BYSI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.90%54.750.9%$2699.34m
JNJJohnson & Johnson 1.44%158.180.7%$1264.42m
MRKMerck & Co., Inc. -0.61%74.450.7%$1166.60m
LLYEli Lilly & Co. 0.48%249.241.1%$741.77m
BMYBristol-Myers Squibb Co. 2.46%54.951.0%$728.65m
ABBVAbbVie, Inc. 0.56%115.921.9%$608.79m
AZNAstraZeneca Plc 0.09%54.881.0%$293.99m
NVSNovartis AG 0.05%79.740.2%$177.39m
GSKGlaxoSmithKline Plc 0.61%41.370.2%$169.27m
DRNADicerna Pharmaceuticals, Inc. 0.24%38.100.3%$140.23m
VTRSViatris, Inc. -1.79%12.090.0%$137.40m
RPRXRoyalty Pharma Plc -2.51%38.770.1%$113.75m
RGENRepligen Corp. -3.37%276.846.7%$113.16m
NVONovo Nordisk A/S 0.42%107.280.1%$94.44m
BFRIBiofrontera, Inc. -27.71%4.330.0%$93.11m

Company Profile

BeyondSpring, Inc. engages in the the development and commercialization of immuno-oncology cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. It operates through PRC and U.S. geographical segments. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.